xylyx

ECM is a key component of the tumor microenvironment that plays a central role in tumor cell proliferation and metastasis. Tissue-specific ECM substrates, including bone, liver, and lung ECMs, offer a robust, physiologically-relevant platform to study migration, invasion, or metastasis, or test compounds or immunotherapies.

Related Resources

3D lung tumor model with lung extracellular matrix to predict drug efficacy
Application note: IN SITE™ Metastasis Kit to accelerate anticancer drug development
Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
Poster: TissueSpec® Bone, Liver, and Lung ECM substrates enable disease-relevant in-vitro models of pre-metastatic tissue microenvironments.
Webinar: Redefining cancer research with IN SITE™ Metastasis Kit